Injectable Delivery

Extreme precision for safer, more accurate dosing

Catalent has over 70 years of experience in providing specialized scientific and manufacturing expertise in complex injectable treatments. As a market leader in sterile manufacturing, we offer an extensively customizable range of prefilled syringe products, uniquely tailored for each customer. We also offer the latest in innovative fill-finish processes, and specialty delivery vehicles such as auto-injectors. Our syringe-filling capacity is over 100 million units.

Catalent Benefits
  • Increase the efficiency of your product with expert solutions
  • Access to specialized technologies that ensure safe and accurate dosing 
  • The latest in innovative injectable safety technology for all needle formats
  • Opportunity for single-dose administration of your products
  • Cost-effective solutions customized to your specifications
  • Highest standards of cleaning, siliconization, and sterilization 
  • Expertise in process design and scale-up, quality assurance, validation, and regulatory support for virtually any sterile dosage form 
Valuable Product Differentiation

 Our prefilled syringes provide distinct advantages over multi-dose:

  • Safe
    • No preservations equals no allergic reactions
    • Less likelihood of medication dosing errors
    • Fewer risks of needle-stick injuries
  • Convenient
    • Accurate single dose of drug product
    • Ready-to-use format
    • Cost-effective
    • Costly waste eliminated by precise filling
Catalent Services 

We offer customized solutions for easier administration: 

  • Syringe-filling 
  • Prefilled syringes
  • Diluents in prefilled syringes 
Facilities
  • Brussels, Belgium
    • 2 Floors: 9,060m
    • Sterile: 2,600m
    • Warehouse: 2,450m
    • Lab: 760m
    • Office: 1,500m
    • EMEA, FDA, ANVISA approved
    • Canadian, Japanese, Australian approved
  • Limoges, France
    • Total: 12000 sq. meters
    • Mfg: 3000 sq. meters
    • Packaging: 1200 sq. meters
    • Warehouse: 6000 sq. meters
    • Lab: 700 sq. meters
    • Office: 800 sq. meters
    • EMEA, ANIVISA, pending FDA approval